- Enoxacin hydrate
-
- $76.00 / 500mg
-
2026-05-11
- CAS:84294-96-2
- Min. Order:
- Purity: 99.86%
- Supply Ability: 10g
- Enoxacin hydrate
-
- $76.00 / 500mg
-
2026-05-11
- CAS:84294-96-2
- Min. Order:
- Purity: 99.86%
- Supply Ability: 10g
- Enoxacin USP/EP/BP
-
- $1.10 / 1g
-
2025-11-18
- CAS:84294-96-2
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
|
| | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate Basic information |
| | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate Chemical Properties |
| Melting point | 226 °C | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | solubility | 1 M NaOH: soluble50mg/mL, clear, colorless to faintly yellow | | form | Solid | | color | White to Off-White | | Merck | 14,3587 | | Stability: | Hygroscopic | | Major Application | clinical testing | | InChI | 1S/2C15H17FN4O3.3H2O/c2*1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20;;;/h2*7-8,17H,2-6H2,1H3,(H,22,23);3*1H2 | | InChIKey | DKNNITGJCMPHKE-UHFFFAOYSA-N | | SMILES | O.O.O.CCN1C=C(C(O)=O)C(=O)c2cc(F)c(nc12)N3CCNCC3.CCN4C=C(C(O)=O)C(=O)c5cc(F)c(nc45)N6CCNCC6 |
| Safety Statements | 24/25 | | WGK Germany | 3 | | HS Code | 29335990 | | Storage Class | 11 - Combustible Solids |
| | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate Usage And Synthesis |
| Uses | antibiotic | | Uses | Enoxacin Sesquihydrate is used to study the sensitivities of Escherichia coli mutant strain to various chemical compounds. | | in vivo | Enoxacin hydrate (Enoxacin sesquihydrate; 100 μM; 2 μl; injected into ear once a day for 3 consecutive days (days 12, 13 and 14)) enhances the the GFP mRNA knockdown efficiency by Lv-siGFP (from 80% to 60%; 40% GFP mRNA level remained), whereas alone has no effect on GFP expression in GFP transgenic line C57BL/6-Tg(ACTB-EGFP)1Osb/J (10 d old) with lentivirus expressing shGFP (Lv-siGFP; injected into ear for 10 days)[3].
| | IC 50 | Quinolone |
| | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate Preparation Products And Raw materials |
|